Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03542838 · ClinicalTrials.gov registry record · Phase 1
Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis
A Phase 1 study, sponsored by Sorrento Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 94
- Enrollment target
NCT03542838: Completed Phase 1 study, sponsored by Sorrento Therapeutics.
NCT03542838 is a Phase 1 study that has completed, run by Sorrento Therapeutics. The registered enrollment target is 94 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03542838, a Phase 1 study, has completed, sponsored by Sorrento Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 94 participants
- Enrollment target
Study Summary
This study evaluates the safety of resiniferatoxin in patients with moderate to severe knee pain due to osteoarthritis.
Primary Outcome
Incidence and severity of adverse events
Interventions
- DRUG Resiniferatoxin
- DRUG Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2021-02-11 |
| Phase | Phase 1 |
What the finished NCT03542838 record still lists
NCT03542838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (57% higher).
The record links to 0 conditions, and to 2 interventions - of which Resiniferatoxin is the first listed.
NCT03542838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03542838 about?
NCT03542838 is a clinical study titled "Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis". This study evaluates the safety of resiniferatoxin in patients with moderate to severe knee pain due to osteoarthritis.
What is the current status of trial NCT03542838?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 94 participants. The study started on 2018-07-12. Estimated completion is 2021-02-11.
What interventions are being tested in trial NCT03542838?
The interventions under investigation include: Resiniferatoxin (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT03542838?
This trial is sponsored by Sorrento Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03542838's enrollment target sits among peer trials
94 615th of 2000 higher than 1,377 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI